Polineni Lab

Principal Investigator

Deepika Polineni, MD, MPH

Associate Professor of Pediatrics (PEFA), Allergy & Pulmonary Medicine
Director, Cystic Fibrosis Center

Recent publications

• Safety of non-cuffed tunneled central venous catheters in adults with cystic fibrosis
  June 1, 2024
  Safety of non-cuffed tunneled central venous catheters in adults with cystic fibrosisDehbozorgi, A., Jandali, B., Turner, R., Rohr, A., Custer, B., Young, K., Walter, C., Clark, L., Li, Y., Polineni, D. & Mermis, J., Jun 2024, In: Respiratory Medicine and Research. 85, 101073.Research output: Contribution to journal › Article › peer-review
• Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis
  April 1, 2024
  Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosisPatel, N., Ansar, M., Pham, A., Thomsen, K., McKinzie, C. J., Polineni, D., Esther, C. R. & Brown, R. F., Apr 2024, In: Pediatric Pulmonology. 59, 4, p. 863-866 4 p.Research output: Contribution to journal › Article › peer-review
• Genetic therapies in cystic fibrosis
  November 1, 2023
  Genetic therapies in cystic fibrosisTaylor-Cousar, J. L., Boyd, A. C., Alton, E. W. F. W. & Polineni, D., Nov 1 2023, In: Current Opinion in Pulmonary Medicine. 29, 6, p. 615-620 6 p.Research output: Contribution to journal › Review article › peer-review
• Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective
  October 1, 2023
  Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveMayer-Hamblett, N., Clancy, J. P., Jain, R., Donaldson, S. H., Fajac, I., Goss, C. H., Polineni, D., Ratjen, F., Quon, B. S., Zemanick, E. T., Bell, S. C., Davies, J. C., Jain, M., Konstan, M. W., Kerper, N. R., LaRosa, T., Mall, M. A., McKone, E., Pearson, K., Pilewski, J. M., & 6 othersQuittell, L., Rayment, J. H., Rowe, S. M., Taylor-Cousar, J. L., Retsch-Bogart, G. & Downey, D. G., Oct 2023, In: The Lancet Respiratory Medicine. 11, 10, p. 932-944 13 p.Research output: […]
• Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis Study
  September 1, 2023
  Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis StudyGifford, A. H., Hinton, A. C., Jia, S., Nasr, S. Z., Mermis, J. D., Lahiri, T., Zemanick, E. T., Teneback, C. C., Flume, P. A., DiMango, E. A., Sadeghi, H., Polineni, D., Dezube, R. H., West, N. E., Dasenbrook, E. C., Lucas, F. L. & Zuckerman, J. B., Sep 2023, In: CHEST. 164, 3, p. 614-624 11 p.Research output: Contribution to journal › Article › peer-review
• Partners in research: The success with therapies research consortium and the CF community unite to improve self-management
  September 1, 2023
  Partners in research: The success with therapies research consortium and the CF community unite to improve self-managementSawicki, G. S., Goodman, A., Bacon, C., Collins, L., Greenberg, J., Duncan, C., Frederick, C., Luebbert, S., Mazuera, S., Polineni, D., Stark, L. L., George, C. & Riekert, K. A., Sep 2023, In: Journal of Cystic Fibrosis. 22, 5, p. 830-835 6 p.Research output: Contribution to journal › Article › peer-review
• Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
  April 1, 2023
  Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsSIMPLIFY Study Group, Apr 2023, In: The Lancet Respiratory Medicine. 11, 4, p. 329-340 12 p.Research output: Contribution to journal › Article › peer-review
• Sex and Gender in Lung Diseases and Sleep Disorders: A State-of-the-Art Review: Part 2
  February 1, 2023
  Sex and Gender in Lung Diseases and Sleep Disorders: A State-of-the-Art Review: Part 2Sodhi, A., Cox-Flaherty, K., Greer, M. K., Lat, T. I., Gao, Y., Polineni, D., Pisani, M. A., Bourjeily, G., Glassberg, M. K. & D'Ambrosio, C., Feb 2023, In: CHEST. 163, 2, p. 366-382 17 p.Research output: Contribution to journal › Review article › peer-review
• Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study
  January 1, 2023
  Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension studyVX17-445-105 Study Group & Polineni, D., 2023, In: European Respiratory Journal. 62, 6Research output: Contribution to journal › Article › peer-review
• Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based care
  November 1, 2022
  Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based careFriedman, D., Smith, B. A., Bruce, A., Schwartz, C. E., Lee, H., Pinsky, H., Gootkind, E., Hardcastle, M., Shea, N., Roach, C. M., Miller, C., Polineni, D., Salathe, M., Quittner, A. L. & Georgiopoulos, A. M., Nov 2022, In: Pediatric Pulmonology. 57, 11, p. 2781-2790 10 p.Research output: Contribution to journal › Article › peer-review

Contact Us